The findings could be good news specifically for women who are diagnosed in the earlier stages of the disease
Women from Black Caribbean and Black African backgrounds are significantly more likely to develop a more advanced form of the disease
The initiative is hoped to contribute towards wider efforts to increase visibility and awareness of the importance of breast screening
The £21 million funding will be open for bids for any AI diagnostic tool that trusts want to deploy
London-based scientists have developed a programme to detect changes in the lymph nodes
The new panel is designed to identify women who are diagnosed with ER+ breast cancer but do not respond to hormone therapy
Companies could benefit from new breast screening recommendations, shows data
The submission is supported by data from more than 700 breast cancer patients across five clinical studies
The London-based company aims to help combat late-stage cancers using proprietary technology
Around 300 women in England with HER2-negative early breast cancer will be eligible for the new drug each year
